App-Quantinova.ai

Mechanical Embolectomy Using a Novel Telescopic System Featuring a Specialized Delivery and 0.088” Aspiration Catheter for the Treatment of Acute Ischemic Stroke

Ben J McGuinness - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Age- and Sex-Specific Temporal Trends in the Incidence of Pediatric Stroke in New York State From 2006-2016

Husitha R Vanguru - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Increased Genetic Risk for Venous Thromboembolism is Associated With Early Onset Ischemic Stroke

Thomas J Jaworek - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Polygenic Risk Scores for Plasma Levels of Fibrin D-Dimer and Tissue Plasminogen Activator Are Associated With Non-Lacunar Stroke

Yonit A Addissie - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Fibrinogen (IV)

Aortic Stenosis and the Risk of Spontaneous Intracerebral Hemorrhage

Jens Witsch - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Risk of All Cause Stroke and Major Bleeding Events When Switching From Warfarin to Apixaban in Patients With Advanced Chronic Kidney Disease and Prevalent Atrial Fibrillation

Katherine Garlo - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

apixaban

Understanding the Role of Microglial Il-1α After Stroke

Eloise Lemarchand - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Collagenase

Portocaval bypass results in treatment patients with the extrahepatic form of portal hypertension

B.N. Kotiv - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Surgical treatment of the hepatocellular carcinoma with portal vein invasion

O.G. Kotenko - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Development of Predictive Models for Medical Adverse Outcomes During and After Primary Total Joint Replacement Surgery Using Obesity and Comorbidity Indicators

B. Sharif - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

Pre-operative prevalence and risk factor for the asymptomatic deep vein thrombosis (DVT) in patients with end-stage knee osteoarthritis

J. Shiozawa - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Icosapent ethyl

Post-surgical predictors of chronic pain after primary knee replacement

S. Khalid - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

Venous thromboembolism after total joint arthroplasty from a Japanese multicenter study with subacute and long term follow-up

K. Kumagai - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Methadone hydrochloride

Prophalaxis of incidence of deep vein thrombosis (VTE) in lower limbs after total knee arthroplasty (TKA) in patients with knee osteoarthritis by eicosapentaenoic acid (EPA) administration – a case-control study

J. Shiozawa - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Icosapent ethyl

A prospective study of persistent postsurgical pain at 1 year after total knee arthroplasty in a Japanese tertiary hospital

S. Takaya - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Variations in the utilization of bilateral total knee arthroplasty in the management of osteoarthritis

B. Mehta - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Inherited CD55 Deficiency in Patients with Early Onset Protein-Losing Enteropathy and Thrombosis

William A Comrie - American Association of Immunologists (AAI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

Thrombomodulin alfa

A Minimum Conditioning Protocol towards Transplantation Tolerance in NOD Mice by Mixed Hematopoietic Chimerism

Jiaxin Lin - American Association of Immunologists (AAI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Cyclophosphamide

Real-time visualisation and quantification of Neutrophil Extracellular Traps

Gillian F. Lovell - American Association of Immunologists (AAI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

Phosphatidylserine

Acute Immune-Mediated Thrombosis and Chronic Thrombophilia causing Acute Ischemic Stroke: a case report

Marialaura Simonetto - American Academy of Neurology (AAN) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

apixaban

Filters

7277 Abstracts